IPM Take
Robotic surgery has spent years proving it can improve precision and reduce invasiveness. The next challenge is no longer technical. It is institutional. A recent telesurgery performed between Guyana and India demonstrates that specialist surgical expertise can now cross borders in real time. Yet licensing systems, liability frameworks, reimbursement models and cybersecurity standards remain largely national. If telesurgery becomes scalable, policymakers will need to answer a question healthcare systems have never faced before: what happens when the surgeon, the patient and the operating room are all located in different jurisdictions?
Executive Summary
SS Innovations recently reported the successful completion of what it describes as the world’s longest-distance robotic telesurgery, with a surgeon in Guyana remotely performing a robotic cardiac procedure on a patient located approximately 20,000 kilometres away in India. The procedure was completed using the company’s SSi Mantra robotic platform and reportedly operated with a communication latency of approximately 300 milliseconds. While the achievement represents a significant technical milestone, it also raises broader questions about regulation, licensing, liability, reimbursement, cybersecurity and health system readiness. As robotic surgery continues to evolve, policymakers may need to develop entirely new governance frameworks for cross-border surgical care.
Why it matters
- Policymakers: Existing healthcare regulations were designed around the assumption that patients and clinicians are located within the same jurisdiction.
- Regulators: Cross-border robotic surgery introduces unanswered questions around licensing, accountability and oversight.
- Hospitals and providers: Future adoption will depend on infrastructure readiness, specialist training and cybersecurity resilience.
- Patients: Telesurgery could eventually expand access to highly specialised procedures in underserved regions and remote communities.
- Industry and innovation partners: Commercial success may depend as much on regulatory acceptance and reimbursement pathways as on technical performance.
For decades, healthcare systems have assumed that surgery is tied to place.
Patients travel to hospitals. Surgeons travel to operating rooms. Specialist expertise is concentrated in major centres and accessed through referral networks.
Robotic telesurgery challenges that model.
In June 2026, SS Innovations announced the successful completion of a robotic cardiac telesurgery performed between Guyana and India, a distance of approximately 20,000 kilometres. According to the company, the procedure established a new record for the longest-distance robotic telesurgery ever completed and was performed using the SSi Mantra surgical robotic system.
The technical milestone is important. The policy implications may be even more significant.
Many health systems face persistent shortages of highly specialised surgical expertise, particularly in cardiovascular care. Rural hospitals, island states and lower-resource regions often struggle to recruit and retain specialist surgeons. In theory, telesurgery could allow expertise to be delivered remotely, reducing geographic barriers to care and extending access to procedures that might otherwise be unavailable.
However, healthcare governance has not evolved at the same pace as surgical technology.
One immediate challenge is professional licensing. If a surgeon located in one country performs a procedure on a patient located in another, which jurisdiction is responsible for oversight? Which medical licence governs the procedure? Which regulator investigates complications if something goes wrong?
Liability frameworks present a second challenge.
Traditional malpractice systems were designed around direct interactions between clinicians and patients within a single healthcare system. Cross-border robotic surgery introduces additional actors, including robotic platform manufacturers, software providers, telecommunications infrastructure operators and healthcare facilities located in multiple jurisdictions. Determining accountability may become significantly more complex.
Cybersecurity is emerging as another policy concern.
Healthcare organisations already face increasing levels of cyberattacks and ransomware incidents. In the context of telesurgery, network reliability becomes more than an operational issue. It becomes a patient safety issue. Future adoption may require entirely new standards for connectivity, cybersecurity certification and system resilience.
The economic implications remain equally uncertain.
Most healthcare systems are still adapting reimbursement models for telemedicine and virtual consultations. Cross-border surgery raises new questions regarding payment, professional fees, insurance coverage and public reimbursement. Existing frameworks offer few answers.
The broader significance extends beyond surgery itself.
Across personalised medicine, expertise is becoming increasingly disconnected from geography. Molecular tumour boards, remote diagnostics, AI-supported interpretation and virtual specialist consultations have already demonstrated that knowledge can move digitally rather than physically. Robotic surgery represents the next step in that evolution: not simply sharing expertise remotely but delivering procedural care remotely.
Whether that future becomes reality will depend less on engineering than on governance.
The Guyana-India procedure demonstrates that the technology is becoming feasible. The challenge now shifts to policymakers, regulators and health systems. Before telesurgery can become routine, they must determine how to govern a world where the surgeon, patient and operating room may no longer be located in the same place.
